Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 1

1(12.5%)

Phase 2

1(12.5%)

8Total

N/A(6)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04322136Not ApplicableCompleted

AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion

Role: collaborator

NCT05156892Phase 1Active Not Recruiting

Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer

Role: collaborator

NCT03734523Completed

Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis

Role: collaborator

NCT03480854Not ApplicableCompleted

The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

Role: collaborator

NCT03586778Not ApplicableWithdrawn

Dry Needling for Patients With Back Pain

Role: lead

NCT02731014Not ApplicableCompleted

Dry Needling for Patients With Neck Pain

Role: collaborator

NCT02413190Completed

Bone Health in Facioscapulohumeral Muscular Dystrophy

Role: collaborator

NCT00227877Not ApplicableCompleted

Screening and Brief Advice to Reduce Teen Substance Use

Role: collaborator

NCT02103504Not ApplicableCompleted

DePuy Attune Total Knee Arthroplasty RSA Study

Role: collaborator

NCT01090817Phase 2Completed

An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease

Role: collaborator

All 10 trials loaded